Our Approach
Our Patient-Centric Medical Facilities
At New Hope Unlimited, we pride ourselves in providing superior comfort, cleanliness, and cancer care at our 8,000 square foot medical treatment center in San Luis Rio Colorado, Mexico. We worked with renowned architects and contractors to create the ideal space for recovery, which includes state-of-the-art lounge areas and spacious private in-rooms that assure the comfort of our patients and their loved ones.
To make our patients feel right at home, we equip each private ward with high-definition U.S. television, quality bedding, and high-speed internet connection. And with proper nutrition playing a vital role in cancer recovery, New Hope Unlimited also fulfills the dietary needs of each patient using fresh, organic produce to prepare breakfasts, lunches, snacks, and dinners.
Comfort and cleanliness are also strictly implemented in our medical treatment rooms, which are equipped with the latest medical supplies and technology to provide the highest standard of care and treatment. Our medical center also has an in-house Hyperbaric Chamber, a well-established therapy for decompression sickness, exclusively available for our patients’ use.
Further, New Hope Unlimited has maintained its exceptional partnership with Hospital Migoo, a medical group composed of certified physicians and specialists committed to our patients’ care and well-being.
Stories of New Hope
Life-changing tales of our cancer patients and survivors.
FAQs
1. Who is at risk for papillary thyroid cancer?
Papillary thyroid cancer is most commonly found in women between the ages of 30 and 50. Still, the malignant disease can develop in anyone, including men.
2. What specific treatments does New Hope Unlimited offer?
From advanced hormone therapy to levorotatory vitamin C supplementation, learn more about the potential alternative papillary thyroid cancer treatments you may receive here.
3. What should I know about papillary thyroid cancer survival rates?
According to the American Cancer Society (ACS), the five-year relative survival rate for localized and regional papillary thyroid is near 100 percent.